MAP3K1 and psoriasis: It inhibits, e.g., IL-1β, IL-8, and TNF-α and slows down the mitogen-activated protein kinase-1 (MEKK-1) pathway in signalling the activation of factor kappa light chain of activated B cells (NF-κB), which is crucial for its anti-skin disease effects (anti-psoriasis activity).